Home/Filings/4/0000930413-19-000024
4//SEC Filing

O'Brien James Michael 4

Accession 0000930413-19-000024

CIK 0000316253other

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 5:02 PM ET

Size

5.7 KB

Accession

0000930413-19-000024

Insider Transaction Report

Form 4
Period: 2019-01-03
O'Brien James Michael
SVP of Finance
Transactions
  • Award

    Stock Option (to acquire common stock)

    2019-01-03+52,00033,666 total
    Exercise: $2.80From: 2020-01-04Exp: 2024-01-02Common Stock (52,000 underlying)
Footnotes (2)
  • [F1]The Reporting Person was granted 52,000 stock options. The options have a five-year term and shall vest in three equal annual tranches, beginning January 4, 2020.
  • [F2]Does not include 10,500 Restricted Stock Units granted to the Reporting Person on January 3, 2019, which will vest, if at all, based upon (i) achievement of average revenue growth and adjusted EBITDA growth goals on January 3, 2022, and (ii) the continued service of the Reporting Person through January 3, 2022.

Documents

1 file

Issuer

ENZO BIOCHEM INC

CIK 0000316253

Entity typeother

Related Parties

1
  • filerCIK 0001632111

Filing Metadata

Form type
4
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 5:02 PM ET
Size
5.7 KB